TUCSON, Ariz., Feb. 10, 2017 -- The Association of American Physicians and Surgeons (AAPS) congratulates Rep. Tom Price, M.D., (R-Ga.) on winning confirmation as Secretary of Health and Human Services (HHS) over bitter opposition.
As reported in the Washington Post, one major objection to Dr. Price was his support for some “unorthodox” views also held by AAPS: freedom for patients and physicians, and the sanctity of the patient-physician relationship.
“HHS has denied or restricted freedom in medicine in countless ways,” states AAPS executive director Jane Orient, M.D. “One step Dr. Price could take immediately is to reverse the HHS policy that forces seniors to accept Medicare Part A or forgo all Social Security benefits.”
As Chris Jacobs explains: “The federal government holds individuals’ Social Security benefits hostage as leverage to forcibly enroll them in Medicare Part A.” Jacobs reports that a lawsuit by several seniors, including former House Majority Leader Dick Armey (Hall v. Sebelius) failed, but the Trump Administration could reverse this policy. Tax savings would likely be modest, but why should the government force tax expenditures for those who would prefer to provide for themselves, he asks.
“Another action that Price could take, in order to protect Medicare patients’ access to independent physicians, is to expand the exemptions in the Final Rule for MACRA, the new Medicare payment methodology,” states Dr. Orient. “HHS has acknowledged the tremendous cost of compliance and the likelihood that small practices will be penalized. The exemption allowed for ‘low volume’ is virtually meaningless—less than $30,000 in Part B charges or fewer than 101 Medicare patients.”
AAPS has recommended that the Final Rule be withdrawn in its entirety. “But at least HHS could abide by Congress’s expressed intention that MACRA be voluntary,” said Dr. Orient. “It could allow patients and physicians to decline MACRA and adopt payment based on patient value rather than by bureaucratically dictated value. It could allow Medicare non-participating (‘non-par’) doctors to choose to be exempt.”
HHS has the authority to set policy that defines non-covered services. “It should declare that patients of non-par doctors may decline to file a claim and have the service considered as ‘non-covered,’ with the fee determined by mutual agreement,” she suggested.
“One thing patients might value is a truly confidential visit of adequate length to discuss all the patient’s concerns. The taxpayer would not be burdened for the visit, and it could save a lot in the long run.”
The Association of American Physicians and Surgeons (AAPS) represents physicians in virtually all specialties and every state. Founded in 1943, AAPS has the motto “omnia pro aegroto,” which means “all for the patient.”
Contact: Jane M. Orient, M.D., (520) 323-3110, [email protected]


China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 



